KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Invested Capital (2016 - 2025)

Pacira BioSciences has reported Return on Invested Capital over the past 13 years, most recently at 0.01% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.01% for Q4 2025, up 12.0% from a year ago — trailing twelve months through Dec 2025 was 0.01% (up 12.0% YoY), and the annual figure for FY2025 was 0.01%, up 9.0%.
  • Return on Invested Capital for Q4 2025 was 0.01% at Pacira BioSciences, down from 0.02% in the prior quarter.
  • Over the last five years, Return on Invested Capital for PCRX hit a ceiling of 0.34% in Q1 2021 and a floor of 0.12% in Q3 2024.
  • Median Return on Invested Capital over the past 5 years was 0.05% (2024), compared with a mean of 0.05%.
  • Peak annual rise in Return on Invested Capital hit 36bps in 2021, while the deepest fall reached -187bps in 2021.
  • Pacira BioSciences' Return on Invested Capital stood at 0.08% in 2021, then fell by -16bps to 0.06% in 2022, then dropped by -16bps to 0.05% in 2023, then plummeted by -304bps to 0.11% in 2024, then surged by 107bps to 0.01% in 2025.
  • The last three reported values for Return on Invested Capital were 0.01% (Q4 2025), 0.02% (Q3 2025), and 0.09% (Q2 2025) per Business Quant data.